CZFS
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Rule-based valuation (P/E + Graham).
- Trades at attractive 8.7x trailing earnings.
- Trades below Graham Number.
Rule-based growth outlook.
- Growth-implied value exceeds price.
Historical performance + price trend: Shares moved +35.3% over 5Y and +19.9% over 1Y.
- Healthy profit margin of 33.3%.
Balance sheet & liquidity (Z-Score: N/A).
- Insufficient data for clear positives.
Dividend policy fallback.
- Yield: 3.0%.
- Weak dividend profile (Score: 35/100).
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CZFS and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CZFS
Citizens Financial Services, Inc.
Primary
|
+35.3% | -15.9% | +19.9% | +19.6% | +8.9% | +8.1% |
|
BCML
BayCom Corp
Peer
|
+112.5% | +64.9% | +12.1% | +8.0% | -2.4% | +0.8% |
|
ARDC
Ares Dynamic Credit Allocation Fund, Inc.
Peer
|
+50.0% | +48.4% | -2.1% | -0.8% | +2.4% | +0.1% |
|
AFB
AllianceBernstein National Municipal Income Fund, Inc.
Peer
|
-4.9% | +10.2% | +4.0% | +9.7% | +2.0% | -1.0% |
|
AGD
Abrdn Global Dynamic Dividend Fund
Peer
|
+81.2% | +68.9% | +36.9% | +14.5% | +4.2% | +0.1% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CZFS
Citizens Financial Services, Inc.
|
NEUTRAL | $317.76M | 8.67 | 11.5% | 33.3% | $66.1 | |
|
BCML
BayCom Corp
|
NEUTRAL | $318.75M | 13.9 | 7.1% | 24.4% | $29.18 | Compare |
|
ARDC
Ares Dynamic Credit...
|
BEARISH | $322.28M | 10.8 | -% | -% | $13.5 | Compare |
|
AFB
AllianceBernstein National...
|
BEARISH | $312.74M | 90.67 | 1.0% | 12.6% | $10.88 | Compare |
|
AGD
Abrdn Global Dynamic Dividend Fund
|
NEUTRAL | $310.97M | 7.1 | 15.7% | 220.6% | $12.5 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | LANDY ROBERT JOSEPH | Director | Gift | 20 | - |
| 2026-03-06 | PAINTER JOHN P II | Director | Purchase | 675 | $41,175 |
| 2026-02-27 | GUILLAUME STEPHEN J | Officer | Purchase | 13 | $742 |
| 2026-01-12 | LANDY ROBERT JOSEPH | Director | Gift | 40 | - |
| 2025-12-22 | BLACK RANDALL E | Chief Executive Officer | Stock Award | 1,552 | - |
| 2025-12-22 | GEPHART LEEANN | Officer | Stock Award | 172 | - |
| 2025-12-15 | OSBORNE TERRY B | Director | Stock Award | 96 | - |
| 2025-12-15 | CHAPPELL ROBERT W | Director | Stock Award | 96 | - |
| 2025-12-15 | DEPAOLA RINALDO A | Director | Stock Award | 96 | - |
| 2025-12-15 | LANDY ROBERT JOSEPH | Director | Stock Award | 96 | - |
| 2025-12-15 | GRAHAM ROGER C JR | Director | Stock Award | 96 | - |
| 2025-12-15 | JONES MICKEY L | Director | Stock Award | 96 | - |
| 2025-12-15 | FREEMAN THOMAS E. | Director | Stock Award | 96 | - |
| 2025-12-15 | KUNES CHRISTOPHER W | Director | Stock Award | 96 | - |
| 2025-12-15 | HILFIGER JANIE M | Director | Stock Award | 96 | - |
Past News Coverage
Recent headlines mentioning CZFS from our newsroom.